Hepatology News

Use of nonselective beta-blockers was associated with stage 2 acute kidney injury and all-cause mortality among patients with decompensated cirrhosis waitlisted for liver transplantation, data showed.

WAILEA, Hawaii — Health care law trends in 2023 were telehealth, whistleblowers, physician referrals and a more intense focus on compliance by providers and practices, according to a law expert speaking at Hawaiian Eye/Retina 2024.

Each January, Alcohol Change UK runs Dry January, a post-holiday campaign that encourages people to abstain from alcohol for 31 days at the beginning of the year and drink more healthily year-round.

“Why should I be investing in bonds when I can earn more than 5% on my cash?” Many investors, including physicians, are asking this question after being discouraged by losses they have experienced with bonds in recent years.

Older adult patients with acute-on-chronic liver failure had significantly higher waitlist mortality but “acceptable” 1-year survival after liver transplantation, according to data in Clinical Gastroenterology and Hepatology.

BOSTON — Residents who learn to screen and treat patients for hepatitis C virus infection in a primary care setting reported feeling more comfortable prescribing treatment, with improved screening rates reported, according to a poster.

Patients with cirrhosis are less frequently screened for osteoporosis compared with the general population, and less than 25% with low bone density actually receive treatment, according to research in Alimentary Pharmacology & Therapeutics.

BOSTON — Nancy S. Reau, MD, FAASLD, AGAF, spoke with Healio about results from the END C study, which evaluated a community-based care model for hepatitis C virus infection among individuals at multiple community homeless sites in England.

BOSTON — In this video, Rohit Loomba, MD, MHSc, discusses data supporting once-monthly dosing of BOS-580, an investigational, long-acting fibroblast growth factor-21 analog for treatment of metabolic dysfunction-associated steatohepatitis.

BOSTON — In this video, Nancy S. Reau, MD, FAASLD, AGAF, reviews three abstracts presented at The Liver Meeting related to pregnancy and pediatric treatments for hepatitis C virus infection.